X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (804) 804
Journal Article (213) 213
Trade Publication Article (27) 27
Publication (15) 15
Book Chapter (7) 7
Book / eBook (4) 4
Conference Proceeding (2) 2
Dissertation (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (100) 100
index medicus (56) 56
male (45) 45
female (44) 44
infectious diseases (38) 38
middle aged (35) 35
aged (28) 28
microbiology (25) 25
infections (24) 24
adult (21) 21
treatment outcome (19) 19
cardiac & cardiovascular systems (18) 18
pharmacology & pharmacy (18) 18
anti-bacterial agents - therapeutic use (17) 17
antibiotics (17) 17
care and treatment (16) 16
orthopedics (14) 14
retrospective studies (14) 14
therapy (14) 14
atrial fibrillation (13) 13
surgery (13) 13
aged, 80 and over (12) 12
diagnosis (12) 12
immunology (12) 12
mortality (12) 12
time factors (12) 12
microbial sensitivity tests (11) 11
risk factors (11) 11
anti-bacterial agents - administration & dosage (10) 10
united states (10) 10
abridged index medicus (9) 9
cardiovascular (9) 9
medicine, general & internal (9) 9
pneumonia (9) 9
prospective studies (9) 9
stroke (9) 9
administration, oral (8) 8
internal medicine (8) 8
prosthesis (8) 8
analysis (7) 7
bacteremia (7) 7
daptomycin - therapeutic use (7) 7
health aspects (7) 7
management (7) 7
patients (7) 7
prosthesis-related infections - diagnosis (7) 7
acyclovir - therapeutic use (6) 6
animals (6) 6
anti-bacterial agents - pharmacology (6) 6
anti-infective agents - therapeutic use (6) 6
anticoagulants (6) 6
cardiology (6) 6
daptomycin (6) 6
defibrillators, implantable - adverse effects (6) 6
disease outbreaks (6) 6
efficacy (6) 6
epidemiology (6) 6
implants, artificial (6) 6
knee arthroplasty (6) 6
prevalence (6) 6
prosthesis-related infections - drug therapy (6) 6
public, environmental & occupational health (6) 6
resistant staphylococcus-aureus (6) 6
risk (6) 6
acyclovir (5) 5
adolescent (5) 5
anti-infective agents - pharmacology (5) 5
anticoagulants - therapeutic use (5) 5
arthroplasty (5) 5
atrial fibrillation - drug therapy (5) 5
bacterial infections - drug therapy (5) 5
blood-stream infections (5) 5
clinical trials as topic (5) 5
diarrhea (5) 5
drug therapy (5) 5
fluoroquinolones (5) 5
follow-up studies (5) 5
gram-positive bacterial infections - drug therapy (5) 5
hemorrhage (5) 5
medical research (5) 5
nursing (5) 5
outcomes (5) 5
prevention (5) 5
prosthesis-related infections - prevention & control (5) 5
quinolones (5) 5
registries (5) 5
risk assessment (5) 5
risk-factors (5) 5
total knee arthroplasty (5) 5
acute disease (4) 4
anti-bacterial agents - adverse effects (4) 4
antimicrobial agents (4) 4
bacteria - drug effects (4) 4
c-reactive protein (4) 4
chemistry, medicinal (4) 4
chicago - epidemiology (4) 4
cohort studies (4) 4
community-acquired pneumonia (4) 4
complications (4) 4
cross infection - epidemiology (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1999, Disease-a-month, Volume 45, no. 7., 267-298.
Book
1987, DM, Volume 33, no. 1., 59
Book
Clinical Infectious Diseases, ISSN 1058-4838, 4/2006, Volume 42, Issue 4, pp. S153 - S163
Extended-spectrum β-lactamases (ESBLs) are plasmid-mediated bacterial enzymes that confer resistance to a broad range of β-lactams. They are descended by... 
Klebsiella | Enzymes | Phenotypes | Cephalosporins | Antibiotics | Antimicrobials | Escherichia coli | Predisposing factors | Bacteria | Infections | 3RD-GENERATION CEPHALOSPORINS | ANTIMICROBIAL SUSCEPTIBILITY | INFECTIOUS DISEASES | BLOOD-STREAM INFECTION | RISK-FACTORS | ESCHERICHIA-COLI | MICRODILUTION PANELS | MICROBIOLOGY | IMMUNOLOGY | ESBL-PRODUCING KLEBSIELLA | PSEUDOMONAS-AERUGINOSA | ENTEROBACTER-CLOACAE | ADVANCED EXPERT-SYSTEM | Enterobacteriaceae - enzymology | Escherichia coli - drug effects | Humans | Enterobacteriaceae Infections - epidemiology | Klebsiella Infections - epidemiology | Microbial Sensitivity Tests - standards | beta-Lactamases - genetics | Escherichia coli - enzymology | Klebsiella Infections - classification | Klebsiella - genetics | Enterobacteriaceae Infections - microbiology | Risk Factors | Enterobacteriaceae - genetics | Escherichia coli Infections - microbiology | Klebsiella - enzymology | Klebsiella Infections - microbiology | Escherichia coli Infections - epidemiology | beta-Lactamases - classification | Klebsiella - drug effects | Escherichia coli - genetics | Enterobacteriaceae - drug effects | Escherichia coli Infections - classification | beta-Lactam Resistance - genetics | beta-Lactamases - isolation & purification | Microbial Sensitivity Tests - methods | Enterobacteriaceae Infections - drug therapy
Journal Article
Journal Article
Journal Article
Clinical Orthopaedics and Related Research, ISSN 0009-921X, 1/2017, Volume 475, Issue 1, pp. 56 - 61
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2013, Volume 57, Issue 9, pp. 4190 - 4196
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 06/2011, Volume 31, Issue 6, pp. 527 - 536
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2010, Volume 32, Issue 10, pp. 1713 - 1719
Abstract Background: The optimal treatment for bloodstream infections (BSIs) with vancomycin-resistant enterococci (VRE) is unknown. Objective: This study... 
Internal Medicine | Medical Education | daptomycin | linezolid | vancomycin-resistant enterococcus | outcomes | resistance | bacteremia | Linezolid | Resistance | Vancomycin-resistant enterococcus | Bacteremia | Outcomes | Daptomycin | STRAINS | QUINUPRISTIN-DALFOPRISTIN | QUINUPRISTIN/DALFOPRISTIN | FAECIUM INFECTIONS | INTERMEDIATE | PHARMACOLOGY & PHARMACY | PROGRAM | Multivariate Analysis | Data Interpretation, Statistical | Prognosis | Vancomycin Resistance - drug effects | Humans | Bacteremia - drug therapy | Gram-Positive Bacterial Infections - mortality | Treatment Outcome | Oxazolidinones - administration & dosage | Oxazolidinones - therapeutic use | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Acetamides - therapeutic use | Enterococcus - isolation & purification | Gram-Positive Bacterial Infections - microbiology | Enterococcus - drug effects | Retrospective Studies | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Acetamides - administration & dosage | Cohort Studies | Daptomycin - therapeutic use | Drug resistance in microorganisms | Medical research | Care and treatment | Medical examination | Comorbidity | Blood | Antibiotics | Analysis | Pharmacy | Endocarditis | Medicine, Experimental | Anti-infective agents | Health aspects | Mathematical optimization
Journal Article
Infectious Diseases in Clinical Practice, ISSN 1056-9103, 09/2012, Volume 20, Issue 5, pp. 299 - 300
Journal Article